AstraZeneca expects U.S. COVID-19 vaccine authorization in April

AstraZeneca Plc expects its COVID-19 vaccine could receive U.S. Emergency Use Authorization at the beginning of April and could immediately deliver 30 million doses of the shot there, a top executive said at a hearing in the U.S. House of Representatives on Tuesday.

Read the full article here

Related Articles